CBSH Trails Peers After Q3 as Analysts Pare Targets

CBSH gained 1.3% over the past week, lagging well behind the median move of roughly 3% for its closest regional bank peers. UCB led the group at 6.3%, FNB and HOMB each added around 3.6%, and even the more sedate CFR and ONB outpaced Commerce at 2.9%. The stock closed Wednesday at $55.14, down nearly 3.5% over the past month.

The relative drag follows a Q3 print that produced a quick round of target cuts. Stephens and Piper Sandler both moved on October 21, with Stephens lowering from $64 to $62 and Piper Sandler from $63 to $60.50, both keeping neutral-to-equal-weight ratings. Those cuts compound a string of downward revisions running back through early October and late September. The contrast with Morgan Stanley remains stark: the firm upgraded to Overweight in September and holds a $77 target, well above the consensus mean of $64.39. That wide gap between the Street's outlier and its majority reflects genuine disagreement about how far NIM expansion and the FineMark integration can go. The bear side points to one-time items in Q2 (including a $105 million Visa gain), low-single-digit loan and deposit growth, and deposit balances that fell 2% annualised. The bull side focuses on pristine credit quality, net charge-offs of 19 basis points, core EPS beating estimates by a meaningful margin in Q2, and management guidance for continued card revenue and wealth management growth.

Short selling pressure is modest and easing. Short interest has drifted down roughly 4.6% over the past month to about 4.7% of the free float, well below the level at which borrow dynamics typically shape the price story. Availability in the lending pool is exceptionally loose, with around 42 million shares available to borrow against 6.2 million currently shorted. Borrowing costs are running near 0.40%, a negligible fee. Options positioning carries a faint defensive tilt: the put/call ratio ticked up to 0.047 on October 21, slightly above its 20-day average, though the absolute reading remains very low for a stock heading into a results release.

The level that would shift the conversation is whether Q3 results show NIM holding at or above the 3.77% posted in Q2. A further sequential expansion would validate Morgan Stanley's Overweight thesis and put the cautious majority back on the defensive; a compression would reinforce the string of target cuts and make Commerce's underperformance relative to peers harder to reverse.